News
Sarepta, Elevidys and gene therapy
Digest more
Sarepta Therapeutics said the Food and Drug Administration informed the company it can lift a voluntary pause on shipments of Elevidys for ambulatory patients with Duchenne. The company said Monday ...
Roche Holding AG said on Tuesday it has paused shipments of muscular disorder gene therapy Elevidys in some countries outside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback